Occasional hepatitis and Mallory bodies formation in hepatocytes has been reported in humans and rodents after griseofulvin treatment [11,12,13], although severe hepatitis is generally observed in rodents, which can be explained by the stronger griseofulvin binding affinity to K18 in rodents than in humans [10]. This evidence concerns the gene KRT18 and hepatitis A virus infection.